Avertix Partners with Institute on Implantable Heart Attack Detection System
By Daniella Parra
Avertix Medical said it was collaborating with the Heart & Rhythm Institute of Trinity to bring an FDA-approved implantable heart attack detection and warning system to patients with high-risk coronary disease, it said.
The implant, called the “Guardian System,” is designed to capture cardiac signals from inside the heart in order to provide life-saving alerts to patients and healthcare professionals, the company said.
“We are pleased to announce the offering of our Guardian System at a leading cardiology ambulatory surgery center in the Tampa Bay area which is served by truly innovative physicians dedicated to providing the highest-quality care for their patients,” said Tim Moran, President and Chief Executive Officer of Avertix. “By expanding availability of the Guardian System, we are well positioned to deliver on our commitment to transforming cardiac care and improving quality of life for heart attack patients who often live in fear of a second heart attack.”
Contact:
Editor@Executives-edge.com
